Literature DB >> 17490600

An intrinsic ATPase activity of phospho-MEK-1 uncoupled from downstream ERK phosphorylation.

Cynthia M Rominger1, Michael D Schaber, Jingsong Yang, Richard R Gontarek, Kurt L Weaver, Timothy Broderick, Luke Carter, Robert A Copeland, Earl W May.   

Abstract

We have developed a highly sensitive assay of MEK-mediated ATP hydrolysis by coupling the formation of ADP to NADH oxidation through the enzymes pyruvate kinase and lactate dehydrogenase. Robust ATP hydrolysis is catalyzed by phosphorylated MEK in the absence of the protein substrate ERK. This ERK-uncoupled ATPase activity is dependent on the phosphorylation status of MEK and is abrogated by the selective MEK kinase inhibitor U0126. ADP production is concomitant with Raf-mediated phosphorylation of MEK. Based on this finding, a coupled Raf/MEK assay is developed for measuring the Raf activity. A kinetic treatment derived under steady-state assumptions is presented for the analysis of the reaction progress curve generated by this coupled assay. We have shown that inhibitory potency of selective Raf inhibitors can be determined accurately by this assay.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17490600     DOI: 10.1016/j.abb.2007.04.004

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  6 in total

Review 1.  Catalytic mechanisms and regulation of protein kinases.

Authors:  Zhihong Wang; Philip A Cole
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

2.  Microfluidic Printing-Based Method for the Multifactorial Study of Cell-Free Protein Networks.

Authors:  Chuqing Zhou; Jiyoung Shim; Zecong Fang; Conary Meyer; Ting Gong; Matthew Wong; Cheemeng Tan; Tingrui Pan
Journal:  Anal Chem       Date:  2022-07-28       Impact factor: 8.008

3.  Evaluating PI3 kinase isoforms using Transcreener ADP assays.

Authors:  Tony A Klink; Karen M Kleman-Leyer; Andrew Kopp; Thane A Westermeyer; Robert G Lowery
Journal:  J Biomol Screen       Date:  2008-06-19

4.  Small-molecule activators of a proenzyme.

Authors:  Dennis W Wolan; Julie A Zorn; Daniel C Gray; James A Wells
Journal:  Science       Date:  2009-11-06       Impact factor: 47.728

5.  Development and validation of a high-throughput intrinsic ATPase activity assay for the discovery of MEKK2 inhibitors.

Authors:  Syed Ahmad; Mark A Hughes; Gary L Johnson; John E Scott
Journal:  J Biomol Screen       Date:  2012-11-07

6.  Dabrafenib; preclinical characterization, increased efficacy when combined with trametinib, while BRAF/MEK tool combination reduced skin lesions.

Authors:  Alastair J King; Marc R Arnone; Maureen R Bleam; Katherine G Moss; Jingsong Yang; Kelly E Fedorowicz; Kimberly N Smitheman; Joseph A Erhardt; Angela Hughes-Earle; Laurie S Kane-Carson; Robert H Sinnamon; Hongwei Qi; Tara R Rheault; David E Uehling; Sylvie G Laquerre
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.